Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, W. J.
Right arrow Articles by Ma, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, W. J.
Right arrow Articles by Ma, N.
Related Collections
Right arrow All Clinical trials
Right arrow All Cerebrovascular disease/Stroke
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrow Infarction
Right arrow Cerebral venous thrombosis
NEUROLOGY 2007;68:420-426
© 2007 American Academy of Neurology

Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis

W. J. Jiang, MD, X. T. Xu, MD, B. Du, MD, K. H. Dong, MD, M. Jin, MD, Q. H. Wang, MD and N. Ma, MD

From the Neurovascular Angioplasty Team, Department of Neurology (K.H.D.), Interventional Neuroradiology (W.J.J., B.D., M.J.), and Neuroradiology (X.T.X., Q.H.W., N.M.), Beijing Tiantan Hospital, The Capital University of Medical Sciences, No. 6 Tiantan Xili, Beijing, China.

Address correspondence and reprint requests to Dr. Wei-Jian Jiang, Department of Neurology and Interventional Neuroradiology, Beijing Tiantan Hospital, The Capital University of Medical Sciences, No. 6 Tiantan Xili, Beijing 100050, China; e-mail: cjr.jiangweijian{at}vip.163.com

Objective: To test whether symptomatic severe intracranial atherosclerotic stenosis was associated with a higher subsequent stroke risk than moderate stenosis after elective angioplasty with a balloon-expandable stent and to explore which factors were associated with the subsequent stroke.

Methods: Between September 2001 and June 2005, there were 220 symptomatic intracranial atherosclerotic stenoses in 213 patients undergoing elective stenting at our institute. Of these stenoses, 126 in 121 patients were ≥70% severe stenoses, and 94 in 92 patients were 50% to 69% moderate stenoses. Primary endpoints included lesion-related ischemic stroke, and symptomatic brain or subarachnoid hemorrhage.

Results: Ten primary endpoint events occurred in the severe stenosis group (six within 30 days and four in mean follow-up of 26.0 months after 30 days), and seven occurred in the moderate stenosis group (four within 30 days and three in mean follow-up of 27.6 months after 30 days). There was no significant difference in cumulative probability of primary endpoints between the severe (7.2% at 1 year and 8.2% at 2 years) and moderate (5.3% at 1 year and 8.3% at 2 years) stenosis groups. No single factor was found to be associated with primary endpoints in the moderate stenosis group. Multivariable analysis revealed that stent failure was the only predictor of primary endpoints in the severe stenosis group (hazard ratio 5.31, 95% CI 1.35 to 20.91).

Conclusion: Symptomatic severe intracranial atherosclerotic stenosis did not present a higher subsequent stroke risk than moderate stenosis after elective angioplasty with a balloon-expandable stent. Patients with severe stenosis may benefit from successful stent placement, and randomized trials are necessary to demonstrate this possible benefit.


Supported by The Ministry of Health of The People’s Republic of China (2004BA714B-7).

Disclosure: The authors report no conflicts of interest.

Received June 28, 2006. Accepted in final form October 13, 2006.




This article has been cited by other articles:


Home page
StrokeHome page
R. Gupta
Symptomatic Intracranial Atherosclerotic Disease: What Is the Best Treatment Option?
Stroke, June 1, 2008; 39(6): 1661 - 1662.
[Full Text] [PDF]


Home page
NeurologyHome page
O. O. Zaidat, R. Klucznik, M. J. Alexander, J. Chaloupka, H. Lutsep, S. Barnwell, M. Mawad, B. Lane, M. J. Lynn, M. Chimowitz, et al.
The NIH registry on use of the Wingspan stent for symptomatic70-99% intracranial arterial stenosis
Neurology, April 22, 2008; 70(17): 1518 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
V. Puetz, G. Gahn, U. Becker, D. Mucha, A. Mueller, N.U. Weir, B. Wiedemann, and R. von Kummer
Endovascular Therapy of Symptomatic Intracranial Stenosis in Patients With Impaired Regional Cerebral Blood Flow or Failure of Medical Therapy
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 273 - 280.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. M. Pelz, E. I. Levy, and L. N. Hopkins
Advances in Interventional Neuroradiology 2007
Stroke, February 1, 2008; 39(2): 268 - 272.
[Full Text] [PDF]


Home page
StrokeHome page
D. Fiorella, E. I. Levy, A. Turk, H. H. Woo, F. C. Albuquerque, and C. G. McDougall
Response to Letter by Gupta et al
Stroke, September 1, 2007; 38(9): e81 - e82.
[Full Text] [PDF]


Home page
StrokeHome page
D. Fiorella and H. H. Woo
Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease
Stroke, August 1, 2007; 38(8): 2391 - 2396.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.